256 related articles for article (PubMed ID: 22337711)
1. Examining the effectiveness of antipsychotic medication in first-episode psychosis.
Taylor M; Cavanagh J; Hodgson R; Tiihonen J
J Psychopharmacol; 2012 May; 26(5 Suppl):27-32. PubMed ID: 22337711
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.
Stroup TS; Alves WM; Hamer RM; Lieberman JA
Nat Rev Drug Discov; 2006 Feb; 5(2):133-46. PubMed ID: 16518380
[TBL] [Abstract][Full Text] [Related]
5. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
Buckley PF
CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
[No Abstract] [Full Text] [Related]
7. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
8. Rational pharmacotherapy in early psychosis.
Remington G
Br J Psychiatry Suppl; 2005 Aug; 48():s77-84. PubMed ID: 16055813
[TBL] [Abstract][Full Text] [Related]
9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
11. Interventions to improve antipsychotic medication adherence: review of recent literature.
Dolder CR; Lacro JP; Leckband S; Jeste DV
J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
[TBL] [Abstract][Full Text] [Related]
12. What do large scale studies of medication in schizophrenia add to our management strategies?
Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
[TBL] [Abstract][Full Text] [Related]
13. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
[TBL] [Abstract][Full Text] [Related]
15. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
[TBL] [Abstract][Full Text] [Related]
16. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
Wyatt RJ; Damiani LM; Henter ID
Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
[TBL] [Abstract][Full Text] [Related]
17. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness in first-episode patients.
Ohlsen RI; O'Toole MS; Purvis RG; Walters JT; Taylor TM; Jones HM; Pilowsky LS
Eur Neuropsychopharmacol; 2004 Nov; 14 Suppl 4():S445-51. PubMed ID: 15572263
[TBL] [Abstract][Full Text] [Related]
19. Suicide attempts by jumping and psychotic illness.
Nielssen O; Glozier N; Babidge N; Reutens S; Andrews D; Gerard A; Malhi GS; Large MM
Aust N Z J Psychiatry; 2010 Jun; 44(6):568-73. PubMed ID: 20482416
[TBL] [Abstract][Full Text] [Related]
20. The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice.
Mahmoud R; Engelhart L; Ollendorf D; Oster G
J Clin Psychiatry; 1999; 60 Suppl 3():42-7; discussion 48. PubMed ID: 10073377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]